SCHEMBL3928078

SCHEMBL3928078

Cc1cc(B(O)O)c(C)cc1B(O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.36
LPL P06858 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
CA1 P00915 1/20 0.33
ENPP2 Q13822 1/20 0.31
CYP3A4 P08684 2/20 0.30
ALOX15 P16050 2/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
MAPT P10636 1/20 0.30
G6PD P11413 1/20 0.30
CYP2C9 P11712 1/20 0.30
PKM P14618 1/20 0.30
HPGD P15428 1/20 0.30
ALOX12 P18054 1/20 0.30
MAPK1 P28482 1/20 0.30
CYP2C19 P33261 1/20 0.30
CCR6 P51684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1513409 0.94 CYP3A4 (0.36) CA2LPLLIPGCA1CYP3A4
SCHEMBL29953127 0.94 CYP3A4 (0.36) CA2LPLLIPGCA1CYP3A4
SCHEMBL12156280 0.84 DAO (0.32)
SCHEMBL20956940 0.84 CD44 (0.42) CYP3A4ALOX15KDM4EALDH1A1MAPT
SCHEMBL12538859 0.84 BCHE (0.35) HPGD
SCHEMBL31621069 0.84 BCHE (0.35) HPGD
SCHEMBL30573112 0.82 BCHE (0.34) HPGD
SCHEMBL5859114 0.80 ENPP2 (0.45) ENPP2ALOX15KDM4EMAPTORAI1
SCHEMBL29956202 0.80 ENPP2 (0.45) ENPP2ALOX15KDM4EMAPTORAI1
SCHEMBL14244142 0.80 ACHE (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119528831-A Triazole organic compound and application thereof 天合光能股份有限公司 2025-02-28 CN disclosed
CN-114031754-B Thermal activation delayed fluorescent polymer and application thereof 南京邮电大学 2024-08-16 CN disclosed
CN-114031754-A Thermally activated delayed fluorescence polymer and application thereof 南京邮电大学 2022-02-11 CN disclosed
US-7732560-B2 Reaction product of a 5,10-dihydroxyterphenyl, 4,4'-thiobis(tetrafluorophenol) and optionally ethynylphenol; for use in the field of hgih speed, information telecommunications and production of highly efficient materials for optical waveguides. GWANGJU INSTITUTE OF SCIENCE OF TECHNOLOGY (KR) 2010-06-08 US disclosed
US-20090259017-A1 TERPHENYL DIHYDROXY MONOMERS CONTAINING FLUORINE AND FLUORINATED POLY(ARYLENE ETHER SULFIDE)S LEE JAE-SUK 2009-10-15 US disclosed
US-20090091244-A1 AMINE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC BLUE-LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2009-04-09 US disclosed
EP-1378532-B1 POLYMER CONTAINING 9-OXO-9-PHOSPHAFLUORENE-2,7-DIYL SKELETON IN BACKBONE AND PROCESS FOR PRODUCING THE SAME JAPAN SCIENCE & TECH AGENCY (JP) 2009-04-01 EP disclosed
US-7033680-B2 Electroluminescent element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-04-25 US disclosed
US-6949621-B2 Polymer containing 9-oxo-9-phosphafluorene-2,7-diyl skeleton in backbone and process for producing the same JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2005-09-27 US disclosed
US-20050106413-A1 Electroluminescent element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-05-19 US disclosed
US-20040019180-A1 Polymer containing 9-oxo-9-phosphafluorene-2,7-diyl skeleton in backbone and process for producing the same EFFECTO, INC. 2004-01-29 US disclosed
EP-1378532-A1 POLYMER CONTAINING 9-OXO-9-PHOSPHAFLUORENE-2,7-DIYL SKELETON IN BACKBONE AND PROCESS FOR PRODUCING THE SAME Japan Science and Technology Corporation (JP) 2004-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090091244-A1 AMINE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC BLUE-LIGHT-EMITTING DEVICE TYR, AOC2, CRY1 CA2 4228/4885LPL 1831/4885LIPG 2758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.